Search

Nucera, Carmelo, Melanie Goldfarb, Richard Hodin, and Sareh Parangi. 2009. “Role of B-Raf(V600E) in Differentiated Thyroid Cancer and Preclinical Validation of Compounds Against B-Raf(V600E).”. Biochimica et Biophysica Acta 1795 (2): 152-61.

Prete, Alessandro, Agnes S Lo, Peter M Sadow, Swati S Bhasin, Zeus A Antonello, Danica M Vodopivec, Soumya Ullas, et al. 2018. “Pericytes Elicit Resistance to Vemurafenib and Sorafenib Therapy in Thyroid Carcinoma via the TSP-1/TGFβ1 Axis.”. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 24 (23): 6078-97.

Duquette, Mark, Peter M Sadow, Amjad Husain, Jennifer N Sims, Zeus A Antonello, Andrew H Fischer, Chen Song, et al. 2015. “Metastasis-Associated MCL1 and P16 Copy Number Alterations Dictate Resistance to Vemurafenib in a BRAFV600E Patient-Derived Papillary Thyroid Carcinoma Preclinical Model.”. Oncotarget 6 (40): 42445-67.

Husain, Amjad, Nina Hu, Peter M Sadow, and Carmelo Nucera. 2016. “Expression of Angiogenic Switch, Cachexia and Inflammation Factors at the Crossroad in Undifferentiated Thyroid Carcinoma With BRAF(V600E).”. Cancer Letters 380 (2): 577-85.

Mekel, Michal, Carmelo Nucera, Richard A Hodin, and Sareh Parangi. 2010. “Surgical Implications of B-RafV600E Mutation in Fine-Needle Aspiration of Thyroid Nodules.”. American Journal of Surgery 200 (1): 136-43.

Nucera, Carmelo, Alessandro Porrello, Zeus Andrea Antonello, Michal Mekel, Matthew A Nehs, Thomas J Giordano, Damien Gerald, et al. 2010. “B-Raf(V600E) and Thrombospondin-1 Promote Thyroid Cancer Progression.”. Proceedings of the National Academy of Sciences of the United States of America 107 (23): 10649-54.

Beroukhim, Rameen, Craig H Mermel, Dale Porter, Guo Wei, Soumya Raychaudhuri, Jerry Donovan, Jordi Barretina, et al. 2010. “The Landscape of Somatic Copy-Number Alteration across Human Cancers.”. Nature 463 (7283): 899-905.

Iesato, Asumi, and Carmelo Nucera. 2021. “Tumor Microenvironment-Associated Pericyte Populations May Impact Therapeutic Response in Thyroid Cancer.”. Advances in Experimental Medicine and Biology 1329: 253-69.

Valvo, Veronica, Asumi Iesato, Taylor R Kavanagh, Carmen Priolo, Zsuzsanna Zsengeller, Alfredo Pontecorvi, Isaac E Stillman, Suzanne D Burke, Xiaowen Liu, and Carmelo Nucera. 2021. “Fine-Tuning Lipid Metabolism by Targeting Mitochondria-Associated Acetyl-CoA-Carboxylase 2 in BRAFV600E Papillary Thyroid Carcinoma.”. Thyroid : Official Journal of the American Thyroid Association 31 (9): 1335-58.

Nucera, Carmelo. 2019. “A Novel Combined Targeted Therapy With Bromodomain Antagonist and MEK Inhibitor in Anaplastic Thyroid Cancer.”. Oncotarget 10 (7): 686-87.